DiscoverThe Wall Street Lab#82 - Laurie Menoud (At One Ventures) - Deep Tech VC Investing as a Way to Net Positivity
#82 - Laurie Menoud (At One Ventures) - Deep Tech VC Investing as a Way to Net Positivity

#82 - Laurie Menoud (At One Ventures) - Deep Tech VC Investing as a Way to Net Positivity

Update: 2022-01-06
Share

Description

Our guest today is Laurie Menoud. Laurie is a Partner at At One Ventures, a VC that finds, funds, and grows deep-tech startups to catalyze a world where humanity is a net positive to nature. Laurie also joined the board of directors of several Startups, and is a multi board observer. Throughout her career Laurie was a Microbiologist, a Biochemist, and Biotechnologist. She was involved in the characterization of the giant virus, "Mimivirus," at the French national laboratory, which shed new light on the origins of life and optimized new biological processes for wastewater treatment. All that, before she turned to VC, where she co-founded A DOZEN! deep-tech startups related to computer vision, Natural Language Processing, diagnostics and robotics during her time at SRI International and later as Co-lead of BASF's North America Venture Capital efforts.

In this episode we talk about Deep Tech VC Investments. We learn how to invest in Biotech, robotics, AI, and much more. Laurie tells us how her background in research, biotech, biochemistry and biology has helped her be a better investor. We talk about investments in companies to lead humanity to a state where we are a net positive to nature. We learn about sourcing deep tech investments, doing due diligence, and helping net positive companies grow. 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#82 - Laurie Menoud (At One Ventures) - Deep Tech VC Investing as a Way to Net Positivity

#82 - Laurie Menoud (At One Ventures) - Deep Tech VC Investing as a Way to Net Positivity

The Wall Street Lab